![]() |
|
|
Vol. 296, Issue 2, 450-457, February 2001
Laboratory of Pharmacology and Chemistry, National Institute of
Environmental Health Sciences, National Institutes of Health,
Research Triangle Park, North Carolina (Y.-H.H, D.H.S., J.B.P.);
and New York Medical College, The New York Eye and Ear Infirmary, New
York, New York (D.-N.H.)
Retinal pigment epithelial (RPE) cells transport a variety of solutes,
but the capacity of human RPE cells to transport drugs and xenobiotics
is not well understood. As an initial step to address this issue, we
have examined human RPE transport of verapamil. Transport of
[3H]verapamil was measured in two human RPE cell lines
(RPE/Hu and ARPE-19) grown to confluence on 12-well culture plates.
Verapamil uptake by RPE/Hu cells was highly concentrative, reaching
cell-to-medium ratios as high as 42 by 1 h. Uptake was saturable,
with an apparent Km of 7.2 µM. Verapamil
uptake decreased in the presence of metabolic inhibitors, low
temperature, and organic cations, including quinidine, pyrilamine,
quinacrine, and diphenhydramine. However, other organic cations,
including tetraethylammonium and cimetidine failed to inhibit.
Verapamil uptake was also inhibited by the cationic antiglaucoma drugs
diltiazem, timolol, and propranolol. Verapamil uptake was insensitive
to changes in membrane potential. However, transport was markedly
altered by changes in pH. Decreasing external pH inhibited uptake,
whereas efflux was stimulated. Intracellular acidification via
NH4Cl prepulse also stimulated uptake. Identical findings
were obtained using the commercially available cell line ARPE-19. In
view of its unique specificity, the RPE cell verapamil transporter
described above is a novel, heretofore undescribed, organic cation
transporter, distinct from the known members of the OCT family of
organic cation transporters.
This article has been cited by other articles:
![]() |
N. Zhang, R. Kannan, C. T. Okamoto, S. J. Ryan, V. H. L. Lee, and D. R. Hinton Characterization of Brimonidine Transport in Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishiguro, T. Nozawa, A. Tsujihata, A. Saito, W. Kishimoto, K. Yokoyama, T. Yotsumoto, K. Sakai, T. Igarashi, and I. Tamai INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER Drug Metab. Dispos., May 1, 2004; 32(5): 519 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Sheu and S.-N. Wu Mechanism of Inhibitory Actions of Oxidizing Agents on Calcium-Activated Potassium Current in Cultured Pigment Epithelial Cells of the Human Retina Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Goralski, G. Lou, M. T. Prowse, V. Gorboulev, C. Volk, H. Koepsell, and D. S. Sitar The Cation Transporters rOCT1 and rOCT2 Interact with Bicarbonate but Play Only a Minor Role for Amantadine Uptake into Rat Renal Proximal Tubules J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 959 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Sweet, D. S. Miller, J. B. Pritchard, Y. Fujiwara, D. R. Beier, and S. K. Nigam Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice J. Biol. Chem., July 19, 2002; 277(30): 26934 - 26943. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cova, U. Laforenza, G. Gastaldi, Y. Sambuy, S. Tritto, A. Faelli, and U. Ventura Guanidine Transport across the Apical and Basolateral Membranes of Human Intestinal Caco-2 Cells Is Mediated by Two Different Mechanisms J. Nutr., July 1, 2002; 132(7): 1995 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gao, A. Wenzel, C. Grimm, S. R. Vavricka, D. Benke, P. J. Meier, and C. E. Reme Localization of Organic Anion Transport Protein 2 in the Apical Region of Rat Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 510 - 514. [Abstract] [Full Text] [PDF] |
||||